mixed material bibliography Boston Harvard Business School Publications November 2015

p. 60 - 63 An interview with Lars Sørensen, chief executive officer (CEO) of the pharmaceutical firm Novo Nordisk, is presented. When asked about diversification, he states that he learned from the company's failed attempt to enter the glucose monitoring sector that it is best to focus on one area in which you can excel. Details on the firm's strategy of selling both generic and differentiated products are presented. Corporate social responsibility is also discussed.<br> 00178012 Perpustakaan - Sekolah Tinggi Manajemen PPM Pusat Informasi Manajemen 46273 2015-12-03 00:00:00 2015-12-03 00:00:00 machine generated